ArticleReviews in cardiovascular medicine2025
Association Between Relative Fat Mass and Cardiometabolic Disease: Age-Stratified Analysis in Young and Middle-Aged Versus Older Adults.
Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current evidence characterizing the association between relative fat mass (RFM) and cardiometabolic disease (CMD) remains limited, with critical gaps persisting in the understanding of age-dependent heterogeneity. Thus, this study aimed to assess the association between RFM and CMD risk across age groups. Methods: This study utilized data from the China Health Evaluation And Risk Reduction Through Nationwide Teamwork (ChinaHEART), and enrolled 93,801 community-dwelling adults. CMD was defined as a composite diagnosis that included diabetes mellitus, myocardial infarction, and stroke. Meanwhile, RFM was derived from height, waist circumference, and sex. Participants were stratified into groups of young and middle-aged adults (35-59 years) and older adults (≥60 years). Multivariable logistic regression models were employed to estimate odds ratios (ORs) and 95% confidence intervals (CIs), and to test for interaction effects. Restricted cubic spline models were applied to examine dose-response relationships. Results: Among the 93,801 participants, 18,473 (19.69%) had CMD. In the fully adjusted models, each unit increase in RFM was associated with a 9% increase in CMD risk (OR = 1.09, 95% CI: 1.08-1.09). Compared to the lowest RFM quartile (Q1), higher risks were observed in the Q2 (1.68, 1.59-1.77), Q3 (2.56, 2.34-2.80), and Q4 (4.02, 3.68-4.39) groups ( Conclusions: RFM demonstrates a significant positive association with CMD risk, exhibiting age-dependent heterogeneity, and emphasizing age-tailored interventions for CMD prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.